Skip to main navigation Skip to search Skip to main content

Lesion detection by [Zr-89]Zr-DFO-girentuximab and [F-18] FDG-PET in patients with newly diagnosed metastatic renal cell carcinoma

  • S. Verhoeff
  • , S. C. van Es
  • , E. Boon
  • , E. van Helden
  • , L. Angus
  • , S. G. Elias
  • , S. F. Oosting
  • , E. H. Aarntzen
  • , A. H. Brouwers
  • , T. C. Kwee
  • , S. Heskamp
  • , O. S. Hoekstra
  • , H. Verheul
  • , G. J. C. Zwezerijnen
  • , C. Menke-van der Houven van Oordt
  • , A. A. M. van der Veldt
  • , E. G. E. de Vries
  • , O. C. Boerman
  • , W. T. A. van der Graaf
  • , W. J. G. Oyen
  • C. M. L. van Herpen

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)S67-S67
JournalEuropean journal of nuclear medicine and molecular imaging
Volume46
Issue numberSUPPL 1
Publication statusPublished - Oct 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this